These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 14639656

  • 1. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [Abstract] [Full Text] [Related]

  • 2. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q.
    Oncogene; 2004 Jun 10; 23(27):4793-806. PubMed ID: 15122337
    [Abstract] [Full Text] [Related]

  • 3. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.
    Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML.
    Int J Cancer; 2004 Nov 20; 112(4):628-35. PubMed ID: 15382043
    [Abstract] [Full Text] [Related]

  • 4. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX.
    Int J Cancer; 2003 Aug 10; 106(1):60-5. PubMed ID: 12794757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
    Chow LS, Lo KW, Kwong J, Wong AY, Huang DP.
    Oncol Rep; 2004 Oct 10; 12(4):781-7. PubMed ID: 15375500
    [Abstract] [Full Text] [Related]

  • 10. NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    Li W, Li X, Wang W, Li X, Tan Y, Yi M, Yang J, McCarthy JB, Xiong W, Wu M, Ma J, Su B, Zhang Z, Liao Q, Xiang B, Li G.
    Carcinogenesis; 2011 Sep 10; 32(9):1305-14. PubMed ID: 21803736
    [Abstract] [Full Text] [Related]

  • 11. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q.
    Oncogene; 2007 Feb 08; 26(6):934-44. PubMed ID: 16862168
    [Abstract] [Full Text] [Related]

  • 12. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.
    Int J Cancer; 2003 Oct 20; 107(1):53-9. PubMed ID: 12925956
    [Abstract] [Full Text] [Related]

  • 13. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, Watanabe G, Murakami Y, Imamura M.
    Cancer Res; 2003 Oct 01; 63(19):6320-6. PubMed ID: 14559819
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G.
    Int J Cancer; 2007 Jan 01; 120(1):32-8. PubMed ID: 17013896
    [Abstract] [Full Text] [Related]

  • 15. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
    Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG, Goggins M.
    Cancer Biol Ther; 2002 Jan 01; 1(3):293-6. PubMed ID: 12432281
    [Abstract] [Full Text] [Related]

  • 16. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP.
    Cancer Res; 2001 May 15; 61(10):3877-81. PubMed ID: 11358799
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
    Oncogene; 2003 Mar 13; 22(10):1580-8. PubMed ID: 12629521
    [Abstract] [Full Text] [Related]

  • 18. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kawata S, Kimura W, Nishizuka S, Murakami Y.
    Jpn J Cancer Res; 2002 Aug 13; 93(8):857-60. PubMed ID: 12716461
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.
    Clin Cancer Res; 2002 Jan 13; 8(1):131-7. PubMed ID: 11801549
    [Abstract] [Full Text] [Related]

  • 20. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q.
    Oncogene; 2006 Feb 16; 25(7):1070-80. PubMed ID: 16247458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.